Close Menu
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Nearly two months after Digene sued Third Wave Technologies for allegedly infringing its human papillomavirus intellectual property, Third Wave last week filed a countersuit with the US District Court for the Western District of Wisconsin, alleging that Digene has “abused its monopoly power to thwart competition” in the HPV diagnostics market.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.